Literature DB >> 12600860

Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women.

Cara L Frankenfeld1, Ruth E Patterson, Neilann K Horner, Marian L Neuhouser, Heather E Skor, Thomas F Kalhorn, William N Howald, Johanna W Lampe.   

Abstract

BACKGROUND: Soy foods may have various health benefits, but little is known about the patterns and correlates of soy consumption among postmenopausal women in the United States.
OBJECTIVE: We assessed the reliability and validity of a soy food-frequency questionnaire (FFQ) and examined demographic, lifestyle, and dietary correlates of plasma isoflavone concentrations in postmenopausal women.
DESIGN: In this cross-sectional study, soy isoflavone intake and plasma isoflavone concentration were analyzed in 96 postmenopausal women aged 50-79 y; the data were obtained at 2 visits that were 1 wk apart. Intake was determined with a 20-item soy FFQ and a comprehensive FFQ that included questions about tofu and soymilk. Fasting plasma daidzein and genistein concentrations were determined with liquid chromatography-mass spectrometry.
RESULTS: Intraclass correlations between week 1 and week 2 values were >0.98 for both the soy and comprehensive FFQs. Median reported isoflavone intake was <2 mg/d. Pearson's product-moment correlation coefficients relating isoflavone intakes with plasma isoflavone concentrations ranged from 0.35 to 0.43. Plasma isoflavone concentrations were positively associated with age, fiber consumption, servings of fruit and vegetables, and dietary supplement use and were inversely associated with caffeine consumption; no associations with body mass index, education, dietary beliefs, activity level, alcohol intake, or fat intake were observed.
CONCLUSIONS: Within a population with low soy consumption, the soy FFQ and comprehensive FFQ showed good reliability and moderate validity. Associations of plasma isoflavone concentrations with other dietary behaviors suggest that these compounds may serve as biomarkers of health behaviors in populations with low soy consumption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600860     DOI: 10.1093/ajcn/77.3.674

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  26 in total

Review 1.  Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter.

Authors:  Kristin M Bircsak; Lauren M Aleksunes
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

2.  Intake of protein-rich foods in relation to outcomes of infertility treatment with assisted reproductive technologies.

Authors:  Feiby L Nassan; Yu-Han Chiu; Jose C Vanegas; Audrey J Gaskins; Paige L Williams; Jennifer B Ford; Jill Attaman; Russ Hauser; Jorge E Chavarro
Journal:  Am J Clin Nutr       Date:  2018-11-01       Impact factor: 7.045

Review 3.  Phytoestrogenic isoflavonoids in epidemiologic and clinical research.

Authors:  Adrian A Franke; Brunhild M Halm; Kerry Kakazu; Xingnan Li; Laurie J Custer
Journal:  Drug Test Anal       Date:  2009-01       Impact factor: 3.345

4.  Urinary isoflavone concentrations are inversely associated with cardiometabolic risk markers in pregnant U.S. women.

Authors:  Ling Shi; Heather Harker Ryan; Emily Jones; Tiffany A Moore Simas; Alice H Lichtenstein; Qi Sun; Laura L Hayman
Journal:  J Nutr       Date:  2013-12-31       Impact factor: 4.798

5.  Brief telephone intervention increases soy intake in peri- and postmenopausal US women: the Herbal Alternatives Trial (HALT).

Authors:  Jeannette M Beasley; Jeannette M Schenk; Evette Ludman; Johanna W Lampe; Susan D Reed; Lou Grothaus; Katherine M Newton
Journal:  J Am Diet Assoc       Date:  2010-08

6.  Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.

Authors:  Kristin M Bircsak; Vivek Gupta; Poi Yu Sofia Yuen; Ludwik Gorczyca; Barry I Weinberger; Anna M Vetrano; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2016-02-05       Impact factor: 4.030

7.  Soy isoflavone intake is associated with risk of Kawasaki disease.

Authors:  Michael A Portman; Sandi L Navarro; Margaret E Bruce; Johanna W Lampe
Journal:  Nutr Res       Date:  2016-04-12       Impact factor: 3.315

8.  Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial.

Authors:  William W Wong; Richard D Lewis; Francene M Steinberg; Michael J Murray; Margaret A Cramer; Paula Amato; Ronald L Young; Stephen Barnes; Kenneth J Ellis; Roman J Shypailo; J Kennard Fraley; Karen L Konzelmann; Joan G Fischer; E O'Brian Smith
Journal:  Am J Clin Nutr       Date:  2009-09-16       Impact factor: 7.045

9.  Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.

Authors:  Neela Guha; Marilyn L Kwan; Charles P Quesenberry; Erin K Weltzien; Adrienne L Castillo; Bette J Caan
Journal:  Breast Cancer Res Treat       Date:  2009-02-17       Impact factor: 4.872

10.  Various doses of soy isoflavones do not modify mammographic density in postmenopausal women.

Authors:  Gertraud Maskarinec; Martijn Verheus; Francene M Steinberg; Paula Amato; Margaret K Cramer; Richard D Lewis; Michael J Murray; Ronald L Young; William W Wong
Journal:  J Nutr       Date:  2009-03-25       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.